Difference between revisions of "FGF14-AS2"
| Line 2: | Line 2: | ||
===Approved Symbol=== | ===Approved Symbol=== | ||
FGF14-AS2 (FGF14 antisense RNA 2) | FGF14-AS2 (FGF14 antisense RNA 2) | ||
| − | [[File:FGF14-AS2 expression in breast cancer in TCGA cohort.jpg|right|thumb| | + | [[File:FGF14-AS2 expression in breast cancer in TCGA cohort.jpg|right|thumb|350px|'''FGF14-AS2 expression in breast cancer in TCGA cohort.'''<ref name="ref1" />]] |
| − | [[File:FGF14-AS2 expression in breast cancer in validated cohort.jpg|right|thumb| | + | [[File:FGF14-AS2 expression in breast cancer in validated cohort.jpg|right|thumb|350px|'''FGF14-AS2 expression in breast cancer in validated cohort.'''<ref name="ref1" />]] |
===Chromosome=== | ===Chromosome=== | ||
13q33.1 | 13q33.1 | ||
Revision as of 07:03, 15 October 2017
Contents
Annotated Information
Approved Symbol
FGF14-AS2 (FGF14 antisense RNA 2)
FGF14-AS2 expression in breast cancer in TCGA cohort.[1]
FGF14-AS2 expression in breast cancer in validated cohort.[1]
Chromosome
13q33.1
RefSeq ID
NR_036487
Expression
Compared with adjacent non-cancerous breast tissues, FGF14-AS2 is down-regulated in breast cancer.[1]
| Experiment | Forward primer | Reverse primer |
|---|---|---|
| qRT-PCR | 5'-AGTTCCAGTTACCATCTTCA- 3' | 5'-AGGTTCATAGTTGCCAGAC- 3'[1] |
Function
FGF14-AS2 is involved in the progress of breast cancer and it plays a tumor suppressor gene role.[1]
Disease
breast cancer [1]
Labs working on this lncRNA
- Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
